Similarly, KMT2C and KMT2D belong to the MLL family of transcriptional coregulators and have been identified as crucial coactivators of AR and potential therapeutic targets in CRPC [71], indicating their altered function in subsets of CaPs may contribute to the observed diverse AR transcriptional outputs. The gene discussed is AR; the disease is cryopyrin-associated periodic syndrome.